# Primary Aldosteronism LC-MS/MS-specific Cutoffs

> **NCT05959863** · — · COMPLETED · sponsor: **Chongqing Medical University** · enrollment: 396 (actual)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **DIAGNOSTIC_TEST:** Captopril Challenge Test

## Key facts

- **NCT ID:** NCT05959863
- **Lead sponsor:** Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 396 (ACTUAL)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05959863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05959863, "Primary Aldosteronism LC-MS/MS-specific Cutoffs". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05959863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*